Day 1
May 22, 2024
| Duration | Name | Topic |
|---|---|---|
| 08:50 - 09:00 | Opening speech | |
| Session 1 — Advisor: Elif Eren | ||
| 09:00 - 09:15 | Elif Cemre Eryigit | TCR-Treg Therapy For Type 2 Autoimmune Hepatitis |
| 09:15 - 09:30 | Meziyet Dilara Reda | The Effect Of TNFR1, TNFR2 And Their Pathways In Preventing The Progression Of Multiple Sclerosis Disease |
| 09:30 - 09:45 | Alihan Arik | Targeting Ferroptosis In Systemic Lupus Erythematosus As A New Therapeutic Approach |
| 09:45 - 10:00 | Feride Gizem Baydemir | Investigating Microglial Dysfunction In Alzheimer's: Mitochondrial Complex I Inhibition To Reduce Neuroinflammation |
| 10:00 - 10:15 | Rumeysa Özgecan Cito | Natural Killer Cell Dysfunction In Recurrent Implantation Failure And Pregnancy Loss |
| Session 2 — Advisor: Merve Seven | ||
| 10:15 - 10:30 | Öykü Şilan Özgür | Genetic Approach to Plant Cold Resilience |
| 15 minutes | Coffee Break | |
| 10:45 - 11:00 | Hicran Bağ | When Vernalization Escapes Control: Impacts on Flower Development |
| 11:00 - 11:15 | Sıla Gökgöl | The Effect of Different Gene Expression in Nasturtium Plants |
| 11:15 - 11:30 | Shefa A Ali Abuabdalah | Suberin for a Cooler World |
| 11:30 - 11:45 | Mürvet Şen | The Role of Transcription Factors in Abiotic Stress Responses and Cell Wall Modifications in Monocot Plants |
| Session 3 — Advisor: Dilek Cevik | ||
| 11:45 - 12:00 | Alp Kus | Potential Rational Therapy Methods Against Immature Teratomas |
| 12:00 - 12:15 | Berke Asrin Sahin | The Intricate Dance Of Circadian Rhythms Genes and Breast Cancer |
| 12:15 - 12:30 | Ali Gokay | Investigation of The Effectiveness of Bacteriophage Therapy |
| 12:30 - 12:45 | Aysegul Kurtulus | Investigation of the Potential Role of Histone Methyltransferase G9a As A Prognostic Biomarker in Cancer |
| Lunch Break | ||
| Session 4 — Advisor: Cemalettin Bekpen | ||
| 13:30 - 13:45 | Bilge Elif Bozokluoğlu | Tuberculosis: is revealing it possible under the lens of new technologies? |
| 13:45 - 14:00 | Selen Kızılkaya | Epigenetic Aspects of Sex Evolution |
| Session 5 — Advisor: Sezai Türkel | ||
| 14:00 - 14:15 | Betül Işık | GLUT4 Translocation as a Regulator of Insulin Resistance in Type 2 Diabetes and Their Regulation by Resveratrol |
| 14:15 - 14:30 | Berin Akçay | The Role of REST/NRSF in Huntington Disease; RESTLIM Domain Protein (RILP) Interaction Can Be Targeted in Huntington Disease Treatment |
| 14:30 - 14:45 | Rasha Abuhazaa | Unveiling the therapeutic potential: exploring the impact of shortchain fatty acids on Alzheimer’s disease |
| 14:45 - 15:00 | Obada Bkeer | Investigating the specific epigenetic targets that are dysregulated in autism spectrum disorder (ASD) and responsible for the core symptoms |
| 15 minutes | Coffee Break | |
| 15:15 - 15:30 | Leen Zaghra | tRNA maturation and its impact on neurodevelopment and neurodegenerative diseases |
| 15:30 - 15:45 | Rehab Badi | Therapeutic Intervention at the Gene Level to Ameliorate Alzheimer’s Diseases Using Small Molecules: Tolfenamic Acid to Be Therapeutic For Alzheimer’s Disease |
| 15:45 - 16:00 | Zeinab Mahmoud | Dysfunctional glucose transport mechanism in brain cells may triggers the development of Alzheimer disease |
| 16:00 - 16:15 | Closing remarks | |
Day 2
May 23, 2024
| Duration | Name | Topic |
|---|---|---|
| Session 1 — Advisor: Cemalettin Bekpen | ||
| 09:00 - 09:15 | Furkan Onur Harmandar | Comprehensive Approach to Extracellular Matrix (ECM) Re-Modeling: The Uncharted Part of Aging |
| 09:15 - 09:30 | Didem Orbay | What is the Secret Behind Multiple Sclerosis: viral approach |
| Session 2 — Advisor: Sezai Türkel | ||
| 09:30 - 09:45 | Elif Dağlı | Development of Pulcherrimin Producing Metschnikowia as a Biocontrol Agent for Multiple Application Fields |
| 09:45 - 10:00 | Shahed Mahmoud | Auto-brewery Syndrome (ABS) and Dysbiosis of the Human Microbiota: Investigating Their Role in Nonalcoholic Fatty Liver Disease |
| 10:00 - 10:15 | Sude Başel | Preventive and Therapeutic Approaches for Gluten Intolerance Diseases in Human |
| 15 minutes | Coffee Break | |
| 10:30 - 10:45 | Özlem Öztürk | Purified killer toxins’ combinations produced by Kluyveromyces, and P. anomala yeast species can be applied against human pathogenic microorganisms as an effective, peptide based biologically safe disinfectant and antimicrobial agents |
| 10:45 - 11:00 | Meryem Riyad | Investigating the role of efflux pumps in multidrug resistance of Staphylococcus iaureus bacteria (MRSA) |
| 11:00 - 11:15 | Emir Çovac | Therapeutic Potential of Benzoxaborole with Quorum Sensing Inhibitors to Prevent Yeast Phenotypic Switch |
| Session 3 — Advisor: Dilek Cevik | ||
| 11:15 - 11:30 | Dareen Yoseef | Investigatıig The Role of Hbv Integration at The Tert Promoter in Hepatocellular Carcinoma Progression |
| 11:30 - 11:45 | Iyad Mustafa | Eradicating Tumor-Initiating Cells in Differentiation Therapy Guides |
| 11:45 - 12:00 | İrem Önal | Unlocking the Future of cccdna as a Therapeutic Target to Treat Chronic Hepatitis B |
| Lunch Break | ||
| Session 4 — Advisor: Merve Seven | ||
| 13:45 - 14:00 | Gül Nezihe Uçuk | The Role of Cyanobacteria in Mitigating Space-Induced Plant Stress |
| 14:15 - 14:30 | Afrah Rafi | Sustainable Production of Alkaloids using Y. Lipolytica |
| 14:30 - 14:45 | Roua Mohammad | Vulnerability of Symbiosis Between Arbuscular Mycorrhizal (AM) Fungi and Panicum virgatum to climate stressors |
| 14:45 - 15:00 | Selin Demiryol | Plant Immunity: Hypersensitive Response (HR) Cell Death Mechanism and New Insights to Resistosome Structure |
| 15 minutes | Coffee Break | |
| Session 5 — Advisor: Elif Eren | ||
| 15:30 - 15:45 | Ceren Süren | Discovering Mutation-Drug Relationships With Dual-Base Editor |
| 15:45 - 16:00 | Maryam Hajiyeva | Utilizing New Bacterial Death Effectors To The Treatment Of Infectious Diseases |
| 16:00 - 16:15 | Mete Savur | Identification Of Structural And Functional Differences In Inflammasome-Related Innate Immunity Genes Between Modern And Archaic Humans |
| 16:15 - 16:30 | Ulyana Pankova | Addressing Allergies And Drug Hypersensitivities: Innovations In Allergen-Specific Immunotherapy And Future Considerations |
| 16:30 - 16:45 | Jury deliberation | |
| 16:45 - 17:00 | Closing remarks and best project awards | |